BRIEF published on 02/27/2025 at 09:02, 9 months 22 days ago GenSight Biologics : Résultats Financiers 2024 et Perspectives Résultats Financiers 2024 Gestion De Trésorerie Financement Futur Térapie Génique Accès Compassionnel LUMEVOQ
BRIEF published on 02/27/2025 at 09:02, 9 months 22 days ago GenSight Biologics: 2024 Financial Results and Outlook Gene Therapy Cash Management Financial Results 2024 Future Financing LUMEVOQ Compassionate Access
PRESS RELEASE published on 02/27/2025 at 08:57, 9 months 22 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie ses résultats financiers estimés pour l'année 2024. L'entreprise prolonge son horizon de trésorerie jusqu'à avril 2025 grâce à une gestion rigoureuse et au Crédit d'Impôt Recherche Résultats Financiers Trésorerie GenSight Biologics Crédit D'Impôt Recherche AAC
PRESS RELEASE published on 02/27/2025 at 08:57, 9 months 22 days ago Inside Information / News release on accounts, results GenSight Biologics reports estimated full-year 2024 consolidated financial results. Cash runway extended to early April 2025. Resumption of Compassionate Access Program expected in April 2025 Financial Results 2024 GenSight Biologics Cash Runway Compassionate Access Program
BRIEF published on 02/12/2025 at 07:35, 10 months 9 days ago GenSight Biologics Reports Positive Five-Year Outcomes for LUMEVOQ® Gene Therapy Gene Therapy LUMEVOQ® Visual Acuity Safety Profile REFLECT Study
BRIEF published on 02/12/2025 at 07:35, 10 months 9 days ago GenSight Biologics annonce des résultats positifs sur cinq ans pour la thérapie génique LUMEVOQ® Thérapie Génique LUMEVOQ® Acuité Visuelle Profil De Sécurité Étude REFLECT
PRESS RELEASE published on 02/12/2025 at 07:30, 10 months 9 days ago Inside Information / Other news releases GenSight Biologics reports 5-year efficacy and safety results for LUMEVOQ® gene therapy in REFLECT study with sustained visual improvement and favorable safety profile Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity REFLECT Study
PRESS RELEASE published on 02/12/2025 at 07:30, 10 months 9 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce les résultats à 5 ans de la thérapie génique LUMEVOQ® pour la NOHL, confirmant l'efficacité durable et le profil de sécurité favorable Sécurité Efficacité Thérapie Génique GenSight Biologics LUMEVOQ
BRIEF published on 01/23/2025 at 18:50, 10 months 29 days ago GenSight Biologics : Bilan Financier et Perspectives GenSight Biologics LUMEVOQ® Augmentations De Capital Accès Compassionnel Trésorerie 2024
BRIEF published on 01/23/2025 at 18:50, 10 months 29 days ago GenSight Biologics: Financial Report and Outlook GenSight Biologics Capital Increases LUMEVOQ® Compassionate Access Treasury 2024
Published on 12/20/2025 at 00:30, 2 days 5 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 7 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 11 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 15 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 16 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/22/2025 at 04:30, 1 hour 17 minutes ago DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
Published on 12/22/2025 at 00:35, 5 hours 12 minutes ago Samsung to Host Series of Tech Forums at CES 2026
Published on 12/22/2025 at 00:05, 5 hours 42 minutes ago Samsung To Unveil AI Vision Built With Google Gemini at CES 2026
Published on 12/21/2025 at 08:55, 20 hours 52 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 13 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/19/2025 at 21:57, 2 days 7 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 21 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 21 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 22 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 22 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
